Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Biogen (BIIB) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2010. Compare with BIIB stock chart to see long term trends.

BIIB stock compared to

BIIB Income Statement

Revenue, Net:2694000000
Revenue Per Share:17.74
Cost of Goods & Services Sold:478100000
Selling, General & Admin Expense:595000000
Research & Development Expense:514200000
Total Operating Expenses:1720100000
Operating Income:973900000
Income Taxes:44200000
Net Income:410200000
Earnings Per Share, Basic:2.7
Shares Outstanding, Basic Avg:151900000

BIIB Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:146900000
Change in Accounts Receiveable:-37200000
Net Cash from Operations:769000000
Repurchases/Buybacks Common Stock:600000000
Net Cash from Financing Activities:-785000000
Property, Plant & Equipment Purchases:92600000
Net Cash from Investing Activities:-64700000
Net Change in Cash & Equivalents:-80700000

BIIB Balance Sheet

Cash and Cash Equivalents:1217500000
Short-Term Investments:2141900000
Accounts Receivable, Net:1854300000
Inventories:1171800000
Total Current Assets:6719500000
Property, Plant & Equipment, Net:3438300000
Total Assets:23854700000
Accounts Payable:430400000
Total Short-Term Liabilities:3165800000
Total Liabilities:13191500000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Primecap Management Co/Ca/
15,696,704 sh
64,772 sh
0%
$4,452,841
$270,518
Blackrock Inc.
14,463,279 sh
-136,177 sh
-1%
$4,102,944
$196,860
Vanguard Group Inc
12,348,072 sh
-528,035 sh
-4%
$3,502,903
$57,902
Wellington Management Group Llp
4,857,192 sh
83,432 sh
2%
$1,377,888
$100,669
Renaissance Technologies LLC
3,816,961 sh
-88,961 sh
-2%
$1,082,795
$37,766
Northern Trust Corp
2,383,190 sh
-54,446 sh
-2%
$676,063
$23,873
Schonfeld Strategic Advisors LLC
Call options for 2,000,000 sh
2,000,000 sh
NEW
$5,674
$5,674
Price T Rowe Associates Inc /Md/
1,371,281 sh
163,403 sh
14%
$389,005
$65,837
UBS Asset Management Americas Inc
1,329,648 sh
20,877 sh
2%
$377,194,546
$27,032,866
Legal & General Group Plc
1,275,188 sh
-35,245 sh
-3%
$361,743
$11,191
FMR LLC
1,084,826 sh
-57,568 sh
-5%
$307,743
$2,095
American Century Companies Inc
1,068,008 sh
35,366 sh
3%
$302,973
$26,690
Bank Of America Corp /De/
917,283 sh
904,183 sh
6902%
$260,215
$256,710
Invesco Ltd.
901,025 sh
-8,357 sh
-1%
$255,602
$12,298
Goldman Sachs Group Inc
886,375 sh
-451,256 sh
-34%
$251,447
-$106,437
Charles Schwab Investment Management Inc
735,080 sh
-90,630 sh
-11%
$208,528
-$12,391
Orbimed Advisors LLC
715,900 sh
 
$203,087
Morgan Stanley
693,397 sh
316,681 sh
84%
$196,704
$95,915
Berkshire Hathaway Inc
643,022 sh
 
$182,412
Prudential Financial Inc
591,724 sh
86,824 sh
17%
$167,860
$32,774

Data imported from Biogen Inc SEC filings. Check original filings before making any investment decision.